Atabak Mokari
2019 - BELLICUM PHARMACEUTICALS
In 2019, Atabak Mokari earned a total compensation of $1.1M as Former Chief Financial Officer at BELLICUM PHARMACEUTICALS.
Compensation breakdown
| Non-Equity Incentive Plan | $61,500 |
|---|---|
| Option Awards | $669,168 |
| Salary | $375,000 |
| Other | $2,233 |
| Total | $1,107,901 |
Mokari received $669.2K in option awards, accounting for 60% of the total pay in 2019.
Mokari also received $61.5K in non-equity incentive plan, $375K in salary and $2.2K in other compensation.
Rankings
In 2019, Atabak Mokari's compensation ranked 8,805th out of 13,971 executives tracked by ExecPay. In other words, Mokari earned more than 37.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,805 out of 13,971 | 37th |
Division Manufacturing | 3,507 out of 5,701 | 39th |
Major group Chemicals And Allied Products | 1,324 out of 2,200 | 40th |
Industry group Drugs | 1,127 out of 1,886 | 40th |
Industry Pharmaceutical Preparations | 837 out of 1,398 | 40th |
Source: SEC filing on April 29, 2021.
Mokari's colleagues
We found three more compensation records of executives who worked with Atabak Mokari at BELLICUM PHARMACEUTICALS in 2019.